TMCnet News

Research and Markets: Global Biochips and Microarrays 2014-218: Technologies, Markets and Companies - Updated 2014 Report

[May 01, 2014]

Research and Markets: Global Biochips and Microarrays 2014-218: Technologies, Markets and Companies - Updated 2014 Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/k3vt7x/biochips_and) has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering.

The report provides current share of each segment: market size in 2012 and projected value for the years 2018 and 2023. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segmentsof microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.

This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.

Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine

Key Topics Covered:

0. Executive Summary

1. Introduction to Virology

2. Antiviral Approaches

3. Vaccines for Virus Infections

4. Role of Nanotechnology in Developing Antiviral Agents

5. Delivery of Antivirals

6. Competitive Assessment of Antiviral Approaches

7. Influenza Viruses

8. AIDS/HIV

9. Hepatitis Viruses

10. Miscellaneous Commercially Important Virus Infections